Literature DB >> 24616482

Serum choline plasmalogens, particularly those with oleic acid in sn-2, are associated with proatherogenic state.

Megumi Nishimukai1, Ryouta Maeba, Yuya Yamazaki, Toru Nezu, Toshihiro Sakurai, Yuji Takahashi, Shu-Ping Hui, Hitoshi Chiba, Tomoki Okazaki, Hiroshi Hara.   

Abstract

Serum plasmalogens (Pls) (1-O-alk-1'-enyl-2-acyl glycerophospholipids) are of particular interest for studies on metabolic disorders associated with oxidative stress and chronic inflammation. Serum levels of Pls are known to correlate positively with HDL-cholesterol (HDL-C); however, few studies have examined serum Pls molecular species in association with pathophysiological conditions and their clinical significance. To clarify these, we determined serum levels of individual ether glycerophospholipids in Japanese asymptomatic cohorts (n = 428; 362 male and 66 female subjects) by LC/MS/MS, and examined their correlations with clinical parameters. We found that the proportion of choline Pls (PlsCho) among total serum phospholipids was significantly lower in the male group over 40 years old and was associated with multiple risk parameters more strongly than HDL-C. The abundance of serum PlsCho with oleic acid (18:1) in sn-2 exhibited the strongest positive correlation with serum concentrations of adiponectin and HDL-C, while being inversely associated with waist circumference and the serum levels of TG and small dense LDL-cholesterol. The characterization of serum ether glycerophospholipids verified the specificity of PlsCho, particularly the ones with 18:1 in sn-2, as a sensitive biomarker for the atherogenic state.

Entities:  

Keywords:  atherosclerosis; ether glycerophospholipid; high density lipoprotein-cholesterol; serum biomarker

Mesh:

Substances:

Year:  2014        PMID: 24616482      PMCID: PMC3995473          DOI: 10.1194/jlr.P045591

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  45 in total

1.  Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry.

Authors:  X Han; D M Holtzman; D W McKeel
Journal:  J Neurochem       Date:  2001-05       Impact factor: 5.372

2.  Deficiency in ethanolamine plasmalogen leads to altered cholesterol transport.

Authors:  Natalie J Munn; Emily Arnio; Dailan Liu; Raphael A Zoeller; Laura Liscum
Journal:  J Lipid Res       Date:  2003-01       Impact factor: 5.922

Review 3.  Functions and biosynthesis of plasmalogens in health and disease.

Authors:  Pedro Brites; Hans R Waterham; Ronald J A Wanders
Journal:  Biochim Biophys Acta       Date:  2004-03-22

Review 4.  Peroxisome proliferator-activated receptor-alpha activation and high-density lipoprotein metabolism.

Authors:  J C Fruchart
Journal:  Am J Cardiol       Date:  2001-12-20       Impact factor: 2.778

5.  Liquid chromatography-mass spectrometric determination of plasmalogens in human plasma.

Authors:  Shu-Ping Hui; Hitoshi Chiba; Takao Kurosawa
Journal:  Anal Bioanal Chem       Date:  2011-04-02       Impact factor: 4.142

6.  High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI.

Authors:  P G Yancey; M de la Llera-Moya; S Swarnakar; P Monzo; S M Klein; M A Connelly; W J Johnson; D L Williams; G H Rothblat
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

7.  In vivo modulation of HDL phospholipid has opposing effects on SR-BI- and ABCA1-mediated cholesterol efflux.

Authors:  Patricia G Yancey; Masa-aki Kawashiri; Ryan Moore; Jane M Glick; David L Williams; Margery A Connelly; Daniel J Rader; George H Rothblat
Journal:  J Lipid Res       Date:  2003-11-01       Impact factor: 5.922

8.  Endothelial lipase-modified high-density lipoprotein exhibits diminished ability to mediate SR-BI (scavenger receptor B type I)-dependent free-cholesterol efflux.

Authors:  Martin Gauster; Olga V Oskolkova; Josef Innerlohinger; Otto Glatter; Gabriele Knipping; Sasa Frank
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

9.  Ethanolamine plasmalogens prevent the oxidation of cholesterol by reducing the oxidizability of cholesterol in phospholipid bilayers.

Authors:  Ryouta Maeba; Nobuo Ueta
Journal:  J Lipid Res       Date:  2003-01       Impact factor: 5.922

10.  Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy.

Authors:  Peter Stenvinkel; Ulf Diczfalusy; Bengt Lindholm; Olof Heimbürger
Journal:  Nephrol Dial Transplant       Date:  2004-04       Impact factor: 5.992

View more
  10 in total

1.  Plasma trimethylamine-N-oxide and related metabolites are associated with type 2 diabetes risk in the Prevención con Dieta Mediterránea (PREDIMED) trial.

Authors:  Christopher Papandreou; Mònica Bulló; Yan Zheng; Miguel Ruiz-Canela; Edward Yu; Marta Guasch-Ferré; Estefanía Toledo; Clary Clish; Dolores Corella; Ramon Estruch; Emilio Ros; Montserrat Fitó; Fernando Arós; Miquel Fiol; José Lapetra; Lluís Serra-Majem; Enrique Gómez-Gracia; Liming Liang; Georgios A Fragkiadakis; Cristina Razquin; Frank B Hu; Jordi Salas-Salvadó
Journal:  Am J Clin Nutr       Date:  2018-07-01       Impact factor: 7.045

2.  Dual mass spectrometry as a tool to improve annotation and quantification in targeted plasma lipidomics.

Authors:  Liang Gao; Amaury Cazenave-Gassiot; Bo Burla; Markus R Wenk; Federico Torta
Journal:  Metabolomics       Date:  2020-04-17       Impact factor: 4.290

3.  Changes in Plasma Lipids during Exposure to Total Sleep Deprivation.

Authors:  Eric Chern-Pin Chua; Guanghou Shui; Amaury Cazenave-Gassiot; Markus R Wenk; Joshua J Gooley
Journal:  Sleep       Date:  2015-11-01       Impact factor: 5.849

4.  Lymphatic Absorption of Microbial Plasmalogens in Rats.

Authors:  Nana Sato; Aki Kanehama; Akiko Kashiwagi; Miwa Yamada; Megumi Nishimukai
Journal:  Front Cell Dev Biol       Date:  2022-03-22

5.  Physical properties, chemical composition, and nutritional evaluation of common salad dressings.

Authors:  Mingyu Yin; Min Chen; Takuya Yanagisawa; Ryosuke Matsuoka; Yinci Xi; Ningping Tao; Xichang Wang
Journal:  Front Nutr       Date:  2022-08-31

6.  Metabolic Architecture of Acute Exercise Response in Middle-Aged Adults in the Community.

Authors:  Matthew Nayor; Ravi V Shah; Patricia E Miller; Jasmine B Blodgett; Melissa Tanguay; Alexander R Pico; Venkatesh L Murthy; Rajeev Malhotra; Nicholas E Houstis; Amy Deik; Kerry A Pierce; Kevin Bullock; Lucas Dailey; Raghava S Velagaleti; Stephanie A Moore; Jennifer E Ho; Aaron L Baggish; Clary B Clish; Martin G Larson; Ramachandran S Vasan; Gregory D Lewis
Journal:  Circulation       Date:  2020-09-15       Impact factor: 29.690

7.  Measurement of Ether Phospholipids in Human Plasma with HPLC-ELSD and LC/ESI-MS After Hydrolysis of Plasma with Phospholipase A1.

Authors:  Shiro Mawatari; Seira Hazeyama; Takehiko Fujino
Journal:  Lipids       Date:  2016-07-07       Impact factor: 1.880

8.  Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice.

Authors:  Edith Miville-Godbout; Mélanie Bourque; Marc Morissette; Sara Al-Sweidi; Tara Smith; Asuka Mochizuki; Vijitha Senanayake; Dushmanthi Jayasinghe; Li Wang; Dayan Goodenowe; Thérèse Di Paolo
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

9.  Enzymatic measurement of ether phospholipids in human plasma after hydrolysis of plasma with phospholipase A1.

Authors:  Shiro Mawatari; Seira Hazeyama; Tomomi Morisaki; Takehiko Fujino
Journal:  Pract Lab Med       Date:  2018-01-09

10.  Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging.

Authors:  Fabian Dorninger; Ann B Moser; Jianqiu Kou; Christoph Wiesinger; Sonja Forss-Petter; Andreas Gleiss; Margareta Hinterberger; Susanne Jungwirth; Peter Fischer; Johannes Berger
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.